Birdwatch Archive

Birdwatch Note Rating

2023-01-16 18:28:01 UTC - SOMEWHAT_HELPFUL

Rated by Participant: C67398AE9626659CE4D2EC0C2BF0F200A32C3EBFFF3E5A9A964AE6504F9D469C
Participant Details

Original Note:

Moderna’s $19 billion profit resulted from extremely incompetent pricing agreed to by US govt. There was no reason for the govt to so grossly overpay for a therapeutic for which Moderna did no marketing, incurred no sales expense, got expedited approval and guaranteed sales.

All Note Details

Original Tweet

All Information

  • noteId - 1614845703829725191
  • participantId -
  • raterParticipantId - C67398AE9626659CE4D2EC0C2BF0F200A32C3EBFFF3E5A9A964AE6504F9D469C
  • createdAtMillis - 1673893681457
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - SOMEWHAT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 1
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1614845703829725191C67398AE9626659CE4D2EC0C2BF0F200A32C3EBFFF3E5A9A964AE6504F9D469C